AR002268A1 - Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas. - Google Patents
Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas.Info
- Publication number
- AR002268A1 AR002268A1 ARP960101026A AR10102696A AR002268A1 AR 002268 A1 AR002268 A1 AR 002268A1 AR P960101026 A ARP960101026 A AR P960101026A AR 10102696 A AR10102696 A AR 10102696A AR 002268 A1 AR002268 A1 AR 002268A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- procedure
- antagonists
- tricyclic
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Abstract
Antagonistas de vasopresina de benzacepina tricíclicos de la fórmula general (I), donde los sustituyentes están definidos en la memoria descriptivaque exhiben actividad antagonista en los receptores V1 y/o V2 y exhiben actividad antagonista de vasopresina in vivo, una composición farmacéutica quelos contiene,el uso de dichos compuestos para preparar medicamentos para tratar enfermedades caracterizadas por exceso de reabsorción renal de agua yprocedimiento para preparar dichos compuestos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/373,139 US5532235A (en) | 1995-01-17 | 1995-01-17 | Tricyclic benzazepine vasopressin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002268A1 true AR002268A1 (es) | 1998-03-11 |
Family
ID=23471147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960101026A AR002268A1 (es) | 1995-01-17 | 1996-01-15 | Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas. |
Country Status (21)
Country | Link |
---|---|
US (2) | US5532235A (es) |
EP (1) | EP0804440B1 (es) |
JP (1) | JP4219978B2 (es) |
CN (1) | CN1061658C (es) |
AR (1) | AR002268A1 (es) |
AT (1) | ATE381570T1 (es) |
AU (1) | AU4775596A (es) |
BR (1) | BR9607186B1 (es) |
CA (1) | CA2210632A1 (es) |
CZ (1) | CZ224897A3 (es) |
DE (1) | DE69637369T2 (es) |
DK (1) | DK0804440T3 (es) |
EA (1) | EA000607B1 (es) |
ES (1) | ES2297835T3 (es) |
HU (1) | HUP9702219A3 (es) |
IL (1) | IL116773A (es) |
MX (1) | MX9705415A (es) |
NZ (1) | NZ302159A (es) |
TW (1) | TW426684B (es) |
WO (1) | WO1996022295A1 (es) |
ZA (1) | ZA96299B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532235A (en) * | 1995-01-17 | 1996-07-02 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
JP2791430B2 (ja) | 1995-11-09 | 1998-08-27 | 日本たばこ産業株式会社 | 縮合ヘテロ5員環アゼピン誘導体及びその医薬用途 |
AU7338796A (en) * | 1995-11-09 | 1997-05-29 | Japan Tobacco Inc. | Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof |
US5880122A (en) * | 1996-11-01 | 1999-03-09 | American Home Products Corporation | 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines |
US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
DK1381608T3 (da) * | 2001-04-12 | 2008-02-04 | Wyeth Corp | Cyclohexylphenylvasopressinagonister |
US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
BR0208823A (pt) | 2001-04-12 | 2004-03-09 | Wyeth Corp | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
US7057046B2 (en) * | 2002-05-20 | 2006-06-06 | Bristol-Myers Squibb Company | Lactam glycogen phosphorylase inhibitors and method of use |
US7098235B2 (en) | 2002-11-14 | 2006-08-29 | Bristol-Myers Squibb Co. | Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
EP1788978B1 (en) * | 2004-09-17 | 2011-11-09 | Codman & Shurtleff, Inc. | Thin film devices for temporary or permanent occlusion of a vessel |
CA2795322A1 (en) | 2010-04-05 | 2011-10-13 | Shionogi & Co., Ltd. | Cephem compound having catechol group |
AU2017270203A1 (en) * | 2016-05-25 | 2019-01-03 | Akarna Therapeutics, Ltd. | Fused bicyclic compounds for the treatment of disease |
TW201920081A (zh) | 2017-07-11 | 2019-06-01 | 美商維泰克斯製藥公司 | 作為鈉通道調節劑的羧醯胺 |
WO2024051590A1 (zh) * | 2022-09-05 | 2024-03-14 | 上海济煜医药科技有限公司 | 苯并氮杂卓并环化合物盐型、晶型及其应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766108A (en) * | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
US5055448A (en) * | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
EP0382185B1 (en) * | 1989-02-10 | 1994-06-15 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
WO1991005549A1 (en) * | 1989-10-20 | 1991-05-02 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
US5070187A (en) * | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
TW199153B (es) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
DE69223573D1 (de) * | 1991-09-16 | 1998-01-29 | Merck & Co Inc | Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten |
EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
WO1994004525A1 (en) * | 1992-08-20 | 1994-03-03 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds as oxytocin and vasopressin antagonists |
AU5533894A (en) * | 1992-11-25 | 1994-06-22 | Yamanouchi Pharmaceutical Co., Ltd. | Benzanilide derivative |
WO1994014796A1 (en) * | 1992-12-21 | 1994-07-07 | Yamanouchi Pharmaceutical Co., Ltd. | Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor |
WO1994020473A1 (en) * | 1993-03-11 | 1994-09-15 | Yamanouchi Pharmaceutical Co., Ltd. | Compound with vasopressin antagonism |
GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
US5512563A (en) * | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
US5532235A (en) * | 1995-01-17 | 1996-07-02 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
-
1995
- 1995-01-17 US US08/373,139 patent/US5532235A/en not_active Expired - Lifetime
-
1996
- 1996-01-15 AR ARP960101026A patent/AR002268A1/es unknown
- 1996-01-15 ZA ZA96299A patent/ZA96299B/xx unknown
- 1996-01-16 HU HU9702219A patent/HUP9702219A3/hu unknown
- 1996-01-16 WO PCT/US1996/001472 patent/WO1996022295A1/en active IP Right Grant
- 1996-01-16 EP EP96903777A patent/EP0804440B1/en not_active Expired - Lifetime
- 1996-01-16 DE DE69637369T patent/DE69637369T2/de not_active Expired - Lifetime
- 1996-01-16 CZ CZ972248A patent/CZ224897A3/cs unknown
- 1996-01-16 CN CN96192597A patent/CN1061658C/zh not_active Expired - Fee Related
- 1996-01-16 TW TW085100459A patent/TW426684B/zh not_active IP Right Cessation
- 1996-01-16 ES ES96903777T patent/ES2297835T3/es not_active Expired - Lifetime
- 1996-01-16 IL IL11677396A patent/IL116773A/xx not_active IP Right Cessation
- 1996-01-16 JP JP52246296A patent/JP4219978B2/ja not_active Expired - Fee Related
- 1996-01-16 AT AT96903777T patent/ATE381570T1/de not_active IP Right Cessation
- 1996-01-16 MX MX9705415A patent/MX9705415A/es unknown
- 1996-01-16 AU AU47755/96A patent/AU4775596A/en not_active Abandoned
- 1996-01-16 DK DK96903777T patent/DK0804440T3/da active
- 1996-01-16 CA CA002210632A patent/CA2210632A1/en not_active Abandoned
- 1996-01-16 EA EA199700111A patent/EA000607B1/ru not_active IP Right Cessation
- 1996-01-16 BR BRPI9607186-9A patent/BR9607186B1/pt not_active IP Right Cessation
- 1996-01-16 NZ NZ302159A patent/NZ302159A/xx unknown
- 1996-05-31 US US08/657,830 patent/US5719278A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
HUP9702219A3 (en) | 1999-05-28 |
US5532235A (en) | 1996-07-02 |
CZ224897A3 (cs) | 1998-04-15 |
EA199700111A1 (ru) | 1997-12-30 |
AU4775596A (en) | 1996-08-07 |
EA000607B1 (ru) | 1999-12-29 |
DE69637369T2 (de) | 2009-01-22 |
CA2210632A1 (en) | 1996-07-25 |
EP0804440A1 (en) | 1997-11-05 |
TW426684B (en) | 2001-03-21 |
DE69637369D1 (de) | 2008-01-31 |
IL116773A (en) | 2000-12-06 |
DK0804440T3 (da) | 2008-03-31 |
JP4219978B2 (ja) | 2009-02-04 |
CN1181084A (zh) | 1998-05-06 |
MX9705415A (es) | 1997-11-29 |
US5719278A (en) | 1998-02-17 |
WO1996022295A1 (en) | 1996-07-25 |
IL116773A0 (en) | 1996-05-14 |
ZA96299B (en) | 1997-07-15 |
HUP9702219A2 (hu) | 1998-07-28 |
CN1061658C (zh) | 2001-02-07 |
JPH10512867A (ja) | 1998-12-08 |
ES2297835T3 (es) | 2008-05-01 |
NZ302159A (en) | 2000-01-28 |
BR9607186B1 (pt) | 2009-01-13 |
EP0804440B1 (en) | 2007-12-19 |
ATE381570T1 (de) | 2008-01-15 |
BR9607186A (pt) | 1997-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002268A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas. | |
ECSP941135A (es) | Antagonistas triciclicos de vasopresina de benzacepina | |
AR002459A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion. | |
ES2134755T3 (es) | Derivados de quinolina como antagonistas de leucotrieno d4, composiciones que contienen los mismos y procedimientos para su preparacion. | |
AR066982A2 (es) | Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos | |
AR062931A2 (es) | Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos | |
AR003938A1 (es) | Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos. | |
BR9810802A (pt) | Composto, composição farmacêutica, e, processos para a preparação de um composto, e para tratamento de uma doença de agregação de plaquetas | |
ES2091877T3 (es) | Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia. | |
AR012172A2 (es) | Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento | |
AR003116A1 (es) | Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para el tratamiento de enfermedades proliferativas, composicion farmaceutica que los comprende y el uso de dichos compuestos para la manufactura de medicamentos | |
HN1999000080A (es) | Derivados de isotiazol utiles como agentes anticancerosos. | |
AR009849A1 (es) | Compuestos estilbenicos de grupo adamantil, composiciones que los contienen y utilizaciones | |
UY26199A1 (es) | Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen | |
UY24986A1 (es) | Compuestos | |
MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
AR006119A1 (es) | Compuestos de quinoxalinadionas uso de los mismos para la fabricacion de un medicamento, compuestos de quinoxalinas para producirlos y procedimiento parala preparacion de los mismos | |
BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
BR9811028A (pt) | Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto | |
BR9909486A (pt) | Compostos calcilìticos | |
ES2095662T3 (es) | Derivados de imidazol con actividad antagonista de la angiotensina ii. | |
AR022970A1 (es) | Compuestos antagonistas de la lhrh con propiedades mejoradas de sulubilidad, procedimiento para prepararlos, las composiciones farmrceuticas que los contienen, su uso para la preparacinn de medicamentos, y procedimiento para preparar dichos medicamentos | |
ES2076595T3 (es) | Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen. | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
CR6398A (es) | Antagonistas de 5ht1 para terapia antidepresiva |